Overview

Gelsemium Sempervirens in Anticipatory Anxiety

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
To evaluate the effectiveness of Gelsemium sempervirens 5CH et 15CH on anticipatory provoked anxiety, in healthy volunteers.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Grenoble
Collaborator:
BOIRON